Organogenesis Holdings (ORGO) Non-Current Deffered Revenue: 2016-2019
Historic Non-Current Deffered Revenue for Organogenesis Holdings (ORGO) over the last 4 years, with Dec 2019 value amounting to $1.0 million.
- Organogenesis Holdings' Non-Current Deffered Revenue rose 49.18% to $1.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.1 million, marking a year-over-year increase of 49.18%. This contributed to the annual value of $1.0 million for FY2019, which is 678.46% up from last year.
- Latest data reveals that Organogenesis Holdings reported Non-Current Deffered Revenue of $1.0 million as of FY2019, which was up 37.50% from $736,000 recorded in FY2019.
- Organogenesis Holdings' 5-year Non-Current Deffered Revenue high stood at $10.8 million for FY2016, and its period low was $74,000 during FY2017.
- Moreover, its 3-year median value for Non-Current Deffered Revenue was $317,500 (2019), whereas its average is $431,167.
- In the last 5 years, Organogenesis Holdings' Non-Current Deffered Revenue plummeted by 99.32% in 2017 and then spiked by 678.46% in 2019.
- Yearly analysis of 4 years shows Organogenesis Holdings' Non-Current Deffered Revenue stood at $10.8 million in 2016, then slumped by 99.32% to $74,000 in 2017, then spiked by 75.68% to $130,000 in 2018, then reached $179,000 in 2019, then reached $456,000 in 2019, then reached $736,000 in 2019, then soared by 678.46% to $1.0 million in 2019.